Structural determinants of dual incretin receptor agonism by tirzepatide

Tirzepatide (LY3298176) is a fatty-acid-modified, dual incretin receptor agonist that exhibits pharmacology similar to native GIP at the glucose-dependent insulinotropic polypeptide receptor (GIPR) but shows bias toward cyclic adenosine monophosphate signaling at the glucagon-like peptide-1 receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bingfa, Willard, Francis S., Feng, Dan, Alsina-Fernandez, Jorge, Chen, Qi, Vieth, Michal, Ho, Joseph D., Showalter, Aaron D., Stutsman, Cynthia, Ding, Liyun, Suter, Todd M., Dunbar, James D., Carpenter, John W., Mohammed, Faiz Ahmad, Aihara, Eitaro, Brown, Robert A., Bueno, Ana B., Emmerson, Paul J., Moyers, Julie S., Kobilka, Tong Sun, Coghlan, Matthew P., Kobilka, Brian K., Sloop, Kyle W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060465/
https://www.ncbi.nlm.nih.gov/pubmed/35333651
http://dx.doi.org/10.1073/pnas.2116506119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060465/
https://www.ncbi.nlm.nih.gov/pubmed/35333651
http://dx.doi.org/10.1073/pnas.2116506119

Ejemplares similares